Vivian Reckers-Droog

Assistant Professor

Erasmus Universiteit Rotterdam Erasmus School of Health Policy and Management

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vivian Reckers-Droog is an Assistant Professor at the Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Netherlands. Her research areas encompass societal preferences in healthcare prioritization, reimbursement decision-making processes, and the impact of budget considerations on health technology evaluations. She has published extensively on topics including the prioritization of patients for surgical capacity and the assessment of orphan drugs in reimbursement contexts.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (2)

Michael Drummond

UNITED KINGDOM

View details

Lucas Goossens

Associate professor

Erasmus University Rotterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vivian Reckers-Droog

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Societal preferences for prioritizing patients suffering from breast cancer, deafness, or knee arthrosis for scarce surgical capacity

The role of budget impact in reimbursement decisions in The Netherlands: interviews with decision-makers and pharmaceutical industry representatives

Societal preferences for granting orphan drugs special status in reimbursement decisions

The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands

Examining the Effect of Depicting a Patient Affected by a Negative Reimbursement Decision in Healthcare on Public Disagreement with the Decision

Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment

Coverage with evidence development for medical devices in Europe: Can practice meet theory?

Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries

Willingness to pay for quality and length of life gains in end of life patients of different ages

Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations

Collaborators (2)

Michael Drummond

Lucas Goossens

Make your next move.